Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension

The effects of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) on dementia risk in patients with type 2 diabetes mellitus (DM) and hypertension remain unknown. We investigated the effects of ACEIs and ARBs on dementia risk in patients with type 2 DM and hypertension.

Source: International Journal of Cardiology - June 26, 2016 Category: Cardiology Authors: Yi-Chun Kuan, Kuang-Wei Huang, Der-Jen Yen, Chaur-Jong Hu, Cheng-Li Lin, Chia-Hung Kao Source Type: research